FHD-286 in Subjects With Metastatic Uveal Melanoma
Clinical trial NCT04879017 · TERMINATED
Trial details
- NCT number
- NCT04879017
- Sponsor
- Foghorn Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-11
- Primary completion
- 2023-11-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.